UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Reliability of a pretransplant i.v. BU test dose performed 2 weeks before myeloablative FluBu conditioning regimen

Bone marrow transplantation (Basingstoke), 2010-02, Vol.45 (2), p.249-253

2010

Volltextzugriff (PDF)

Improved outcomes with novel agents and auto-SCT for multiple myeloma in African-American patients

Bone marrow transplantation (Basingstoke), 2013-02, Vol.48 (2), p.319-320

2013

Volltextzugriff (PDF)

High-dose chemotherapy with autologous transplantation for persistent/relapsed ovarian cancer: a multivariate analysis of survival for 100 consecutively treated patients

Journal of clinical oncology, 1997-04, Vol.15 (4), p.1309-1317

1997

Volltextzugriff (PDF)

T-cell immunity to the joining region of p210BCR-ABL protein

Proceedings of the National Academy of Sciences - PNAS, 1992-02, Vol.89 (4), p.1468-1472

1992

Volltextzugriff (PDF)

Toxicity and therapeutic efficacy of high-dose interleukin 2: in vivo infusion of antibody to NK-1.1 attenuates toxicity without compromising efficacy against murine leukemia

The Journal of experimental medicine, 1989, Vol.169 (1), p.161-173

1989

Volltextzugriff (PDF)

T cell recognition of transforming proteins encoded by mutated ras proto-oncogenes

The Journal of immunology (1950), 1991-03, Vol.146 (6), p.2059-2065

1991

Volltextzugriff (PDF)

Lysis of ras oncogene-transformed cells by specific cytotoxic T lymphocytes elicited by primary in vitro immunization with mutated ras peptide

The Journal of experimental medicine, 1994-02, Vol.179 (2), p.473-479

1994

Volltextzugriff (PDF)

CD4+ T-cell immunity to mutated ras protein in pancreatic and colon cancer patients

Cancer research (Chicago, Ill.), 1995-07, Vol.55 (14), p.2984-2987

1995

Volltextzugriff (PDF)

Eradication of disseminated murine leukemia by treatment with high-dose interleukin 2

The Journal of immunology (1950), 1986-12, Vol.137 (11), p.3675-3680

1986

Volltextzugriff (PDF)

IL-4-induced lymphokine-activated killer cells. Lytic activity is mediated by phenotypically distinct natural killer-like and T cell-like large granular lymphocytes

The Journal of immunology (1950), 1988-05, Vol.140 (10), p.3679-3685

1988

Volltextzugriff (PDF)

Efficient transfer of PSA and PSMA cDNAs into DCs generates antibody and T cell antitumor responses in vivo

Cancer gene therapy, 2005-06, Vol.12 (6), p.540-551

2005

Volltextzugriff (PDF)

A phase I trial of interleukin 3 (IL-3) pre-bone marrow harvest with granulocyte-macrophage colony-stimulating factor (GM-CSF) post-stem cell infusion in patients with solid tumours receiving high-dose combination chemotherapy

Bone marrow transplantation (Basingstoke), 1995-11, Vol.16 (5), p.655-661

1995

Volltextzugriff (PDF)

Distinct cytokine patterns exist in peripheral blood mononuclear cell cultures of patients with prostate cancer

Clinical Immunology, 2005-10, Vol.117 (1), p.94-99

2005

Volltextzugriff (PDF)

Induction of human cytotoxic T lymphocytes specific for prostate-specific antigen

The Prostate, 1997-02, Vol.30 (2), p.73-78

1997

Volltextzugriff (PDF)

Antigen-driven T cell clones can proliferate in vivo, eradicate disseminated leukemia, and provide specific immunologic memory

The Journal of immunology (1950), 1987-06, Vol.138 (11), p.4012-4017

1987

Volltextzugriff (PDF)

Induction of Tc2 cells with specificity for prostate-specific antigen from patients with hormone-refractory prostate cancer

Cancer Immunology, Immunotherapy, 2002-07, Vol.51 (5), p.263-270

2002

Volltextzugriff (PDF)

Geographic access to hematopoietic stem cell transplantation (HSCT)

Journal of clinical oncology, 2010-05, Vol.28 (15_suppl), p.e16517-e16517

2010

Volltextzugriff (PDF)

Changes in Telomerase Activity and Telomere Length during Human T Lymphocyte Senescence

Experimental cell research, 1997-03, Vol.231 (2), p.346-353

1997

Volltextzugriff (PDF)

Potential Uses of Interleukin 2 in Cancer Therapy

Immunobiology (1979), 1986-09, Vol.172 (3), p.365-382

1986

Volltextzugriff (PDF)

Induction of specific T cell immunity in patients with prostate cancer by vaccination with PSA146-154 peptide

Cancer Immunology, Immunotherapy, 2006-09, Vol.55 (9), p.1033-1042

2006

Volltextzugriff (PDF)

Il-4 is an endogenous T cell growth factor during the immune response to a syngeneic retrovirus-induced tumor

The Journal of immunology (1950), 1988-10, Vol.141 (8), p.2824-2830

1988

Volltextzugriff (PDF)

Antibody to ras proteins in patients with colon cancer

Clinical cancer research, 1995-10, Vol.1 (10), p.1071-1077

1995

Volltextzugriff (PDF)

Metal-on-Metal Local Tissue Reaction Is Associated With Corrosion of the Head Taper Junction

The Journal of arthroplasty, 2012-09, Vol.27 (8), p.26-31.e1

2012

Volltextzugriff (PDF)

Intracoronary Enalaprilat to Reduce Microvascular Damage During Percutaneous Coronary Intervention (ProMicro) Study

Journal of the American College of Cardiology, 2013-02, Vol.61 (6), p.615-621

2013

Volltextzugriff (PDF)

Effects of Prasugrel Versus Clopidogrel on Coronary Microvascular Function in Patients Undergoing Elective PCI

Journal of the American College of Cardiology, 2016-07, Vol.68 (2), p.235-237

2016

Volltextzugriff (PDF)

1 – 25 von 349

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(314)
Mit Volltextzugriff
(271)

Publikationsform

Sprache

Englisch
(341)
Französisch
(9)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Reliability of a pretransplant i.v. BU test dose performed 2 weeks before myeloablative FluBu conditioning regimen

Improved outcomes with novel agents and auto-SCT for multiple myeloma in African-American patients

High-dose chemotherapy with autologous transplantation for persistent/relapsed ovarian cancer: a multivariate analysis of survival for 100 consecutively treated patients

T-cell immunity to the joining region of p210BCR-ABL protein

Toxicity and therapeutic efficacy of high-dose interleukin 2: in vivo infusion of antibody to NK-1.1 attenuates toxicity without compromising efficacy against murine leukemia

T cell recognition of transforming proteins encoded by mutated ras proto-oncogenes

Lysis of ras oncogene-transformed cells by specific cytotoxic T lymphocytes elicited by primary in vitro immunization with mutated ras peptide

CD4+ T-cell immunity to mutated ras protein in pancreatic and colon cancer patients

Eradication of disseminated murine leukemia by treatment with high-dose interleukin 2

IL-4-induced lymphokine-activated killer cells. Lytic activity is mediated by phenotypically distinct natural killer-like and T cell-like large granular lymphocytes

Efficient transfer of PSA and PSMA cDNAs into DCs generates antibody and T cell antitumor responses in vivo

A phase I trial of interleukin 3 (IL-3) pre-bone marrow harvest with granulocyte-macrophage colony-stimulating factor (GM-CSF) post-stem cell infusion in patients with solid tumours receiving high-dose combination chemotherapy

Distinct cytokine patterns exist in peripheral blood mononuclear cell cultures of patients with prostate cancer

Induction of human cytotoxic T lymphocytes specific for prostate-specific antigen

Antigen-driven T cell clones can proliferate in vivo, eradicate disseminated leukemia, and provide specific immunologic memory

Induction of Tc2 cells with specificity for prostate-specific antigen from patients with hormone-refractory prostate cancer

Geographic access to hematopoietic stem cell transplantation (HSCT)

Changes in Telomerase Activity and Telomere Length during Human T Lymphocyte Senescence

Potential Uses of Interleukin 2 in Cancer Therapy

Induction of specific T cell immunity in patients with prostate cancer by vaccination with PSA146-154 peptide

Il-4 is an endogenous T cell growth factor during the immune response to a syngeneic retrovirus-induced tumor

Antibody to ras proteins in patients with colon cancer

Metal-on-Metal Local Tissue Reaction Is Associated With Corrosion of the Head Taper Junction

Intracoronary Enalaprilat to Reduce Microvascular Damage During Percutaneous Coronary Intervention (ProMicro) Study

Effects of Prasugrel Versus Clopidogrel on Coronary Microvascular Function in Patients Undergoing Elective PCI

Suchergebnisse filtern